四维血流磁共振成像评估肝硬化肝细胞癌患者经导管动脉化疗栓塞术后治疗反应
前瞻性研究纳入195例肝硬化患者,分为无肝细胞癌组、肝细胞癌TACE术前组、TACE术后不完全反应组和TACE术后完全反应组,采用3-T磁共振四维血流成像测量门静脉、脾静脉和肠系膜上静脉血流定量参数。结果显示门静脉和脾静脉多项血流参数在术前组和不完全反应组显著低于无肝细胞癌组,门静脉平均穿平面速度和峰值速度幅度与TACE术后完全反应独立相关,四维血流磁共振成像获取的定量血流数据可能有助于预测肝硬化肝细胞癌患者TACE术后完全反应。
要点
- 四维血流磁共振成像可定量测量门静脉、脾静脉和肠系膜上静脉血流参数。
- 门静脉平均穿平面速度和峰值速度幅度与TACE术后完全反应独立相关。
- 术前组和不完全反应组门静脉及脾静脉多项血流参数低于无肝细胞癌组。
核心结论
- 四维血流磁共振成像获取的定量血流数据可能有助于预测肝硬化肝细胞癌患者经导管动脉化疗栓塞术后完全反应。
研究设计与样本
- 前瞻性研究,共纳入195例患者分为四组:A组为无肝细胞癌的肝硬化患者(n=30),B组为TACE术前肝细胞癌肝硬化患者(n=75),C组为TACE术后不完全反应的肝细胞癌肝硬化患者(n=56),D组为TACE术后达到完全反应的肝细胞癌肝硬化患者(n=34);采用3-T磁共振系统进行四维血流磁共振成像,测量门静脉、脾静脉和肠系膜上静脉血流定量参数,并行常规实验室检查。
诊断标准与关键数值
- 门静脉和脾静脉的平均穿平面速度、峰值速度幅度、平均净流量、峰值流量和净前向容积在B组和C组显著低于A组(P < 0.05);门静脉平均穿平面速度和峰值速度幅度在B组和C组显著低于D组(P < 0.05);多因素分析显示门静脉平均穿平面速度和峰值速度幅度与肝细胞癌患者TACE术后完全反应独立相关(P < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To prospectively evaluate the potential of four-dimensional (4D) flow magnetic resonance imaging (MRI) in predicting treatment responses after transcatheter arterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma (HCC).
METHODS: A total of 195 patients were classified into four groups (A-D): A, cirrhotic patients without HCC (n = 30); B, cirrhotic patients with HCC before TACE (n = 75); C, cirrhotic patients with HCC showing an incomplete response following TACE (n = 56); and D, cirrhotic patients with HCC achieving a complete response (CR) following TACE (n = 34). The patients were subjected to routine laboratory tests and 4D flow MRI using a 3-T MRI system to measure the quantitative parameters of blood flow in the portal vein (PV), splenic vein (SV), and superior mesenteric vein. The data collected by 4D flow MRI were compared among the groups using one-way analysis of variance. A multivariate analysis was performed to verify the association of clinical characteristics and 4D flow parameters with CR after TACE treatment.
RESULTS: The average through-plane velocity, peak velocity magnitude, average net flow, peak flow, and net forward volume in the PV and SV were significantly lower in groups B and C (P < 0.05) compared to those in group A. Moreover, average through-plane velocity and peak velocity magnitude in the PV in groups B and C were significantly lower than those in group D (P < 0.05). The multivariate analysis demonstrated that the average through-plane velocity and peak velocity magnitude in the PV were independently associated with CR in HCC patients after TACE (P < 0.05).
CONCLUSION: The quantitative flow data obtained by 4D flow MRI may be useful for predicting CR after TACE in cirrhotic patients with HCC.
引用
- Moon CM, Lee YY, Kim SK, et al. Four-dimensional flow MR imaging for evaluating treatment response after transcatheter arterial chemoembolization in cirrhotic patients with hepatocellular carcinoma. Radiol Med. 2023. PMID: 37505380. doi:10.1007/s11547-023-01685-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。